Background The seroprotection rate (SPR) of hepatitis B vaccination in adults is suboptimal.
The aim of this study was to compare the SPR of a tri-antigenic hepatitis B vaccine (TAV) …

Importance There is a need for improved immunogenicity of hepatitis B virus (HBV) vaccines
among young adults with risk of infection. Objectives To demonstrate manufacturing …

Present hepatitis B vaccines use multidose prolonged regimens, which even healthcare
workers at risk do not always complete. Moreover, when vaccination is completed there …

Hepatitis B and its sequelae are a major public health problem. Vaccines have been
available for almost 20 years; however the disease still remains a global problem. Many …

Background The standard three-dose schedule of hepatitis B vaccines is frequently not
completed, especially in adolescents. A primary study has confirmed the equivalence of a …

The immunogenicity of three currently used hepatitis B vaccines was compared in an
unselected study population in an every day travel clinical setting. Five hundred and …

Background. Hepatitis B vaccine has been shown to be highly efficient in preventing
hepatitis B. However, 5%–10% of individuals fail to develop protective levels (≥ 10 mIU/mL) …

This article presents the World Health Organization's (WHO) recommendations on the use of
hepatitis B vaccines excerpted from the Hepatitis B vaccines: WHO position paper, July …

Background Universal anti-hepatitis-B vaccination of infants and adolescents was
implemented in Italy in 1991. We undertook a multicentre study in previously vaccinated …

A post-marketing, double blind, randomised, controlled clinical trial to assess the
immunogenicity and safety profiles of four commercially available recombinant hepatitis B …